Biomarker May Predict HPV-Related Oropharyngeal Cancer Outcomes
By analyzing variations in the level of human papillomavirus (HPV) in oropharyngeal cancers, researchers at the University of Texas MD Anderson Cancer Center.
Industry News
Industry News
Protein That Halts Gum Inflammation Also May Improve Stem Cell Transplants
A protein called Del-1 prevents inflammatory cells from moving into the gums, making it a potential drug target for gum disease. It also.
Industry News
Protein That Halts Gum Inflammation Also May Improve Stem Cell Transplants
A protein called Del-1 prevents inflammatory cells from moving into the gums, making it a potential drug target for gum disease. It also.
Todays Dental News
Risks Remain With Oral Cancer Surgery
Head and neck cancer is increasing worldwide. During the past 15 years, oral and neck cancer has increased from 2,000 to 8,000 new.
Industry News
Reduced Radiation Improves Outcomes for HPV-Positive Oropharynx Cancer Patients
Oropharynx cancers that test positive for the human papillomavirus (HPV) have been rising. After radiation treatment, these patients often experience severe, lifelong swallowing,.
Industry News
Reduced Radiation Improves Outcomes for HPV-Positive Oropharynx Cancer Patients
Oropharynx cancers that test positive for the human papillomavirus (HPV) have been rising. After radiation treatment, these patients often experience severe, lifelong swallowing,.
Industry News
Immunotherapy Improves Survival Rates of Advanced Head and Neck Cancer Patients
A new immunotherapy drug known as nivolumab greatly improves survival for patients with relapsed head and neck cancer, as more than twice as.
Industry News
Rocker Beats Oral Cancer with Immunotherapy
Rikki Rockett, drummer with the rock band Poison, was diagnosed with oral cancer a little more than a year ago. Now, the tumor.
Industry News
Rocker Beats Oral Cancer with Immunotherapy
Rikki Rockett, drummer with the rock band Poison, was diagnosed with oral cancer a little more than a year ago. Now, the tumor.
Industry News
NIH Grant Will Develop Cannabinoid Cancer Treatment
Oral cancer is a painful disease, affecting 45,750 new patients each year in the United States. Cannabinoids (CBs) represent one alternative to opioid.
